Literature DB >> 9564840

The dipsogenic effects of rat relaxin: The effect of photoperiod and the potential role of relaxin on drinking in pregnancy.

A J Summerlee1, D J Hornsby, D G Ramsey.   

Abstract

Experiments were done to examine whether rat relaxin is dipsogenic and whether such dipsogenic effects of rat relaxin are related to time of injection during the light-dark cycle. Female rats were fitted with a chronic intra-cerebro-ventricular (i.c.v.) cannula. Rat relaxin (2.5, 5, 10, 25, 50, or 100 ng/2 microl in 0.9% saline) was injected into the right lateral ventricle at either morning (0800-1000 h), afternoon (1400-1600 h), or night (2200-2400 h), and water consumption was measured. Relaxin caused a dose-dependent dipsogenesis at doses > or = 5 ng, but the sensitivity and magnitude of the response varied with the photoperiod. Water consumption was smallest (3.5 +/- 0.7 ml at 50 ng) and least sensitive (minimal effective dose at 25 ng) in the afternoon and maximal (17.7 +/- 2.3 ml at 50 ng) and most sensitive (minimal effective dose 5 ng) at night. The latency from injection to drinking was 55.8 +/- 10.4 sec (mean +/- SEM) and did not vary significantly with either the dose or time of day. A second set of experiments was done to examine the effects of neutralizing the central actions of relaxin on drinking behavior in pregnancy. Pregnant rats were injected daily, through a chronically implanted i.c.v. cannula, with either a specific monoclonal antibody raised against rat relaxin from day 12 to day 22 of gestation or with saline as a control. Drinking and eating behavior and weight gain were monitored every 12 h during pregnancy. There was a significant decrease in water consumed at night, but no effect on drinking during the day in relaxin-neutralized rats. These animals also showed a decrease in weight gain during pregnancy compared with controls and gave birth to lighter-weight litters. These data provide evidence that the dipsogenic response to exogenous rat relaxin in female rats varies with time of injection during the light-dark cycle and suggest that relaxin in the brain may have a role in nighttime drinking behavior during the second half of pregnancy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9564840     DOI: 10.1210/endo.139.5.5966

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Relaxin is a potent renal vasodilator in conscious rats.

Authors:  L A Danielson; O D Sherwood; K P Conrad
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

2.  Relaxin increases sympathetic nerve activity and activates spinally projecting neurons in the paraventricular nucleus of nonpregnant, but not pregnant, rats.

Authors:  K Max Coldren; Randall Brown; Eileen M Hasser; Cheryl M Heesch
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-09-23       Impact factor: 3.619

Review 3.  Relaxin family peptide systems and the central nervous system.

Authors:  G E Callander; R A D Bathgate
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

4.  Relaxin peptide hormones are protective during the early stages of ischemic stroke in male rats.

Authors:  Lindsay H Bergeron; Jordan M Willcox; Faisal J Alibhai; Barry J Connell; Tarek M Saleh; Brian C Wilson; Alastair J S Summerlee
Journal:  Endocrinology       Date:  2014-12-02       Impact factor: 4.736

Review 5.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

6.  The cardiovascular effects of porcine relaxin in Brattleboro rats.

Authors:  L J Parry; B C Wilson; R S Poterski; A J Summerlee
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

7.  Synthesis of fluorescent analogs of relaxin family peptides and their preliminary in vitro and in vivo characterization.

Authors:  Linda J Chan; Craig M Smith; Berenice E Chua; Feng Lin; Ross A D Bathgate; Frances Separovic; Andrew L Gundlach; Mohammed Akhter Hossain; John D Wade
Journal:  Front Chem       Date:  2013-12-06       Impact factor: 5.221

8.  Analgesic effect of central relaxin receptor activation on persistent inflammatory pain in mice: behavioral and neurochemical data.

Authors:  Cynthia Abboud; Louison Brochoire; Adèle Drouet; M Akhter Hossain; Walid Hleihel; Andrew L Gundlach; Marc Landry
Journal:  Pain Rep       Date:  2021-06-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.